Ronald C Mcglennen

6546787, Apr 15, 2003

Mar 25, 1999

09/276076

Peter J. Schiller - Coon Rapids MN
Angela K. Drexler - Maplewood MN
David R. Wulfman - Minneapolis MN
Ronald C. McGlennen - Edina MN

Regents of the University of Minnesota - Minneapolis MN

G01N 300

73 85, 73781

Diagnostic imaging methods, methods of detecting the margin of tissue structures and bioresponsive needle systems are disclosed. The methods rely on the use of strain signals provided by a strain gage mounted on the wall of one or more needles as the needle or needles are moved through tissue. The systems employ a strain gage mounted on the wall of the needle and a strain monitor providing feedback to a user.

8594948, Nov 26, 2013

Jul 9, 2010

12/833209

Ronald C. McGlennen - Edina MN, US
Naomi M. Williamson - Fridley MN, US
Aaron M. Franks - Eden Prairie MN, US
David J. Olson - Minnetrista MN, US
Robert P. Schuldt - Eagan MN, US

G06F 7/00

702 19, 702 20, 703 11, 707700, 435 61, 435 71, 436501

Apparatus and methods for practicing telemedicine in the form of software systems acting over a network and kits containing laboratory supplies and equipment to organize the laboratory operations and interpret the results of molecular diagnostic testing are disclosed. At least two computers in communication over the Internet or other network are used, a remote computer located at a remote site and a central server located at a central site. The remote site may be geographically distant from the central site. A specimen is procured from a patient proximate to the remote site. Laboratory operations are conducted on the specimen at the remote site. The laboratory data resulting from the laboratory operations is interpreted by an expert reviewer who may be located at the central site, and a report is then transmitted back to the remote site.

20010048088, Dec 6, 2001

Oct 19, 1999

09/230915

DENNIS L. POLLA - ROSEVILLE MN, US
RONALD C. MCGLENNEN - EDINA MN, US

F16K031/02

251/129060, 417/418000, 251/011000

A precision controller of the movement of at least a first fluid, includes a precision motor. Valve apparatus is operably coupled to the precision motor. Orifice apparatus is fluidly coupled to a source of fluid and to the valve apparatus, whereby actuation of the valve apparatus by the precision motor acts to selectively expose and cover the orifice to implement fluid valving.

20040014097, Jan 22, 2004

Apr 7, 2003

10/409337

Ronald McGlennen - Edina MN, US
Naomi Williamson - Fridley MN, US
Aaron Franks - Hopkins MN, US
Sabine Holmes - Minneapolis MN, US
Robert Schuldt - Eagan MN, US

G06F017/60
C12Q001/68
G06F019/00
G01N033/48
G01N033/50

435/006000, 702/020000, 705/003000

The invention involves creation of an integrated genetic testing kit. The kit combines materials and components to aid in performance of each of the steps in a genetic assay. Additionally, the invention describes a variety of electronic tools and adjunct materials to make easier the collection and organization of patient related information that is used in interpretation of the analytic genetic data. One aspect of this invention is as a stand-alone integrated test kit, the test results of which may be in the form of fluoroscopic output. Another aspect of this invention is a telemedicine model. In this model, the invention is a larger genetic testing system in which procurement of genetic material, its testing, and its interpretation may occur at different locations. The telemedicine model comprises the integrated kit, instrumentation, and an electronic transmission system for delivery of the genetic test data to a remote data system where it is interpreted and a report is generated.

20060240449, Oct 26, 2006

Jan 19, 2006

11/336665

Ronald McGlennen - Edina MN, US
David Olson - Minnetrista MN, US
Elaine Stores - New Brighton MN, US
Aaron Franks - Eden Prairie MN, US
Naomi Williamson - Fridley MN, US

C12Q 1/68
C12N 1/08

435006000, 435270000

Methods and compositions for preparation of biological samples are disclosed. The methods include a prelysis step and a lysis step to make the cellular DNA available for further processing, amplification or analysis. The prelysis step includes the addition of a prelysis reagent to the cells. The prelysis reagent may include an enzyme to facilitate the disruption of the cells. The lysis step includes the addition of a lysis reagent to at least a portion of the prelysis reagent and cells.

20060264714, Nov 23, 2006

Jul 27, 2006

11/494371

Ronald McGlennen - Edina MN, US
Naomi Williamson - Fridley MN, US
Aaron Franks - Eden Prairie MN, US
David Olson - Minnetrista MN, US
Robert Schuldt - Eagan MN, US

A61B 5/00

600300000, 128920000

Apparatus and methods for practicing telemedicine in the form of software systems acting over a network and kits containing laboratory supplies and equipment to organize the laboratory operations and interpret the results of molecular diagnostic testing are disclosed. At least two computers in communication over the Internet or other network are used, a remote computer located at a remote site and a central server located at a central site. The remote site may be geographically distant from the central site. A specimen is procured from a patient proximate to the remote site. Laboratory operations are conducted on the specimen at the remote site. The laboratory data resulting from the laboratory operations is interpreted by an expert reviewer who may be located at the central site, and a report is then transmitted back to the remote site.

20060278242, Dec 14, 2006

Mar 23, 2006

11/389435

Ronald McGlennen - Edina MN, US
Naomi Williamson - Fridley MN, US
Aaron Franks - Eden Prairie MN, US
David Olson - Minnetrista MN, US
Robert Schuldt - Eagan MN, US

A61B 19/00

128898000

Apparatus and methods for practicing telemedicine in the form of software systems acting over a network and kits containing laboratory supplies and equipment to organize the laboratory operations and interpret the results of molecular diagnostic testing are disclosed. At least two computers in communication over the Internet or other network are used, a remote computer located at a remote site and a central server located at a central site. The remote site may be geographically distant from the central site. A specimen is procured from a patient proximate to the remote site. Laboratory operations are conducted on the specimen at the remote site. The laboratory data resulting from the laboratory operations is interpreted by an expert reviewer who may be located at the central site, and a report is then transmitted back to the remote site.

20070238100, Oct 11, 2007

Nov 30, 2005

11/290854

Ronald McGlennen - Edina MN, US
David Olson - Minnetrista MN, US
Susie Del Rio LaFreniere - Andover MN, US

C12Q 1/68
C07H 21/04

435006000, 536024320

Methods and compositions for detecting, typing or characterizing HPV DNA are disclosed. The methods can include isolation of DNA from a patient and amplifying any L1 region of HPV in the sample. The amplicon from the L1 region may be analyzed to determine at least one of the presence of HPV, the type of the HPV and the risk category of any HPV. The compositions can include one or more primer sets for amplification of the L1 region of HPV.